Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 1
1998 1
1999 1
2002 3
2003 4
2004 2
2005 5
2006 6
2007 5
2008 7
2009 6
2010 14
2011 8
2012 9
2013 6
2014 13
2015 13
2016 10
2017 9
2018 14
2019 12
2020 15
2021 11
2022 14
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28856610

169 results

Results by year

Filters applied: . Clear all
Page 1
Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe graves' orbitopathy (GO): a prospective, randomized, single-blind clinical trial.
Moleti M, Violi MA, Montanini D, Trombetta C, Di Bella B, Sturniolo G, Presti S, Alibrandi A, Campennì A, Baldari S, Trimarchi F, Vermiglio F. Moleti M, et al. J Clin Endocrinol Metab. 2014 May;99(5):1783-9. doi: 10.1210/jc.2013-3093. Epub 2014 Jan 16. J Clin Endocrinol Metab. 2014. PMID: 24432992 Clinical Trial.
Total thyroid ablation in Graves' orbitopathy.
Menconi F, Leo M, Vitti P, Marcocci C, Marinò M. Menconi F, et al. J Endocrinol Invest. 2015 Aug;38(8):809-15. doi: 10.1007/s40618-015-0255-1. Epub 2015 Mar 5. J Endocrinol Invest. 2015. PMID: 25740065 Review.
Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, Pasquini C, Piazza F, Caciagli M, Mariani G. Barbaro D, et al. J Clin Endocrinol Metab. 2003 Sep;88(9):4110-5. doi: 10.1210/jc.2003-030298. J Clin Endocrinol Metab. 2003. PMID: 12970272 Clinical Trial.
Serum thyroglobulin is associated with orbitopathy in Graves' disease.
Khamisi S, Lundqvist M, Emadi P, Almby K, Ljunggren Ö, Karlsson FA. Khamisi S, et al. J Endocrinol Invest. 2021 Sep;44(9):1905-1911. doi: 10.1007/s40618-021-01505-8. Epub 2021 Jan 29. J Endocrinol Invest. 2021. PMID: 33515213 Free PMC article.
169 results